Cardiac physiology in transgenic mice

Circulation Research

Volumn 82, Issue 4, 1998, Pages 407-415

  James, Jeanne F ^a   Hewett, Timothy E ^a   Robbins, Jeffrey ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b Division of Molecular Cardiovascular Biology   (United States)

Author keywords

Gene; Heart; Physiology; Transgenesis

Indexed keywords

ANIMAL MODEL; BLOOD PRESSURE MEASUREMENT; ECHOCARDIOGRAPHY; EXERCISE; HEART; HEART ELECTROPHYSIOLOGY; ISOLATED HEART; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENIC MOUSE;

EID: 0032498785     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.4.407     Document Type: Short Survey

References (37)

1. Melton DW. Gene targeting in the mouse. Bioessays. 1994;16:633-638.
2. Christemen G, Wang YB, Chien KR. Physiological assessment of complex cardiac phenotypes in genetically engineered mice. Am J Physiol. 1997;41:H2513-H2524.
3. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 1993;265:H1401-H1410.
4. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res. 1994;75:401-409.
5. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science. 1994;264:582-586.
6. Palermo J, Gulick J, Colbert M, Fewell J, Robbins J. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ Res. 1996;78:504-509.
7. Kumar A, Crawford K, Close L, Madison M, Abbas Z, Lorenz J, Doetschman T, Pawlowski S, Duffy J, Neumann J, Robbins J, Boivin G, O'Toole B, Lessard JL. Rescue of cardiac actin deficient mice by enteric actin. Proc Natl Acad Sci U S A. 1997;94:4406-4411.
8. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, Robbins J. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest. 1996;98:1906-1917.
9. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731-734.
10. Hunter JJ, Tanaka N, Rockman HA, Ross JJ, Chien KR. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem. 1995;270:23173-23178.
11. sα overexpression. Circ Res. 1996;78:517-524.
12. Gottshall KR, Hunter JJ, Tanaka N, Dalton N, Becker KD, Ross J Jr. Chien KR. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc Natl Acad Sci U S A. 1997;94:4710-4715.
13. Lorenz J, Robbins J. Measurement of intraventricular pressure and cardiac performance in the intact closed chest anesthetized mouse. Am J Physiol. 1997;272:H1137-H1146.
14. Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A. 1996;93:10483-10488.
15. Colbert MC, Hall G, Kimball TR, Witt SA, Lorenz JA, Kirby ML, Hewett TE, Klevitsky R, Robbins J. Cardiac compartment specific overexpression of a modified RAR produces close dependent changes in systolic function, dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest. 1997;100:1958-1968.
16. Berul CI, Aronovitz MJ, Wang PJ, Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation. 1996;94:2641-2648.
17. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest. 1997;99:570-576.
18. Manning WJ, Wei JY, Katz SE, Litwin SE, Douglas PS. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol. 1994;266:H1672-H1675.
19. Gardin JM, Siri FM, Kitsis RN, Edwards JG, Leinwand LA. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res. 1995;76:907-914.
20. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross JJ. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;94:1109-1117.
21. Iwase M, Uechi M, Vatner DE, Asai K, Shannon RP, Kudej RK, Wagner TE, Wight DC, Patrick TA, Ishikawa Y, Homcy CJ, Vatner SF. Cardiomyopathy induced by cardiac Gs alpha overexpression. Am J Physiol. 1997;272:H585-H589.
22. Srinivasan S, Artman M, Baldwin HS, Turnbull DH. High frequency ultrasound study of murine embryonic heart development in utero. Circulation. 1997;96(suppl I):I-685. Abstract.
23. Keller BB, MacLennan MJ, Tinney JP, Yoshigi M. In vivo assessment of embryonic cardiovascular dimensions and function in day-10.5 to -14.5 mouse embryos. Circ Res. 1996;79:247-255.
24. Gui YH, Linask KK, Khowsathit P, Huhta JC. Doppler echocardiography of normal and abnormal embryonic mouse heart. Pediatr Res. 1996;40:633-642.
25. Siri FM, Jelicks LA, Leinwand LA, Gardin JM. Gated magnetic resonance imaging of normal and hypertrophied murine hearts. Am J Physiol. 1997;272:H2394-H2402.
26. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res. 1997;81:627-635.
27. Kramer K, van Acker S, Voss H-P, Grimbergen JA, van der Vijgh WJF, Bast A. Use of telemetry to record electrocardiogram and heart rate in freely moving mice. J Pharmacol Toxicol Methods. 1993;30:209-215.
28. Mansier P, Medigue C, Charlotte N, Yermeiren C, Coraboeuf E, Deroubai E, Ratner E, Chevalier B, Clairambault J, Carre F, Dahkli T, Bertin B, Briand P, Strosberg D, Swynghedauw B. Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors. Am J Physiol. 1996;271:H1465-H1472.
29. sα. Circ Res. 1998;82:416-423.
30. Fewell JG, Osinska H, Klevitsky R, Ng WE, Sfyris G, Bahrehmand F, Robbins J. A treadmill exercise regimen for identifying subtle cardiovascular phenotypes in transgenic mice overexpressing myosin regulatory light chain 2v. Am J Physiol. 1997;273:H1595-H1605.
31. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995;25:1111-1115.
32. Kaplan ML, Cheslow Y, Vikstrom K, Malhotra A, Geenen DL, Nakouzi A, Leinwand LA, Buttrick PM. Cardiac adaptations to chronic exercise in mice. Am J Physiol. 1994;267:H1167-H1173.
33. Desai KH, Sato R, Schauble E, Barsh GS, Kobilka BK, Bernstein D. Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease. Am J Physiol. 1997;272:H1053-H1061.
34. Gulick J, Hewett TE, Klevitsky R, Buck S, Moss RL, Robbins J. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res. 1997;80:655-664
35. Diamond LE, McCurry KR, Martin MJ, McClellan SB, Oldham ER, Platt JL, Logan JS. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation. 1996;61:1241-1249.
36. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD. Gene recombination in postmitotic cells: targeted expression of cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest. 1997;100:169-179.
37. Yu Z, Redfern CS, Fishman GI. Conditional transgene expression in the heart. Circ Res. 1996;79:691-697.